SCHEMBL3322440

SCHEMBL3322440

CN(Cc1cccs1)C(=O)C1(c2ccc(Cl)cc2)CCCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 9/20 1.00
CYP3A4 P08684 3/20 0.72
CYP2D6 P10635 1/20 0.72
CYP2C9 P11712 1/20 0.72
MAPT P10636 2/20 0.46
LMNA P02545 1/20 0.46
TSHR P16473 1/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RIPK1 Q13546 1/20 0.45
ALDH1A1 P00352 2/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
HDAC4 P56524 1/20 0.44
TACR3 P29371 1/20 0.43
THRB P10828 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
TAAR1 Q96RJ0 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3328484 0.99 HSD11B1 (0.98) HSD11B1CYP3A4CYP2D6CYP2C9MAPT
SCHEMBL3323891 0.91 HSD11B1 (0.83) HSD11B1CYP3A4CYP2D6CYP2C9MAPT
SCHEMBL3326634 0.88 HSD11B1 (0.78) HSD11B1CYP3A4CYP2D6CYP2C9MAPT
SCHEMBL19248209 0.84 HSD11B1 (1.00) HSD11B1CYP3A4CYP2D6CYP2C9RIPK1
SCHEMBL3323043 0.78 HSD11B1 (1.00) HSD11B1CYP3A4CYP2D6CYP2C9NPSR1
SCHEMBL17285680 0.78 HSD11B1 (0.63) HSD11B1MAPTLMNANPSR1ALDH1A1
SCHEMBL3318166 0.77 HSD11B1 (0.63) HSD11B1MAPTLMNAHTTALDH1A1
SCHEMBL3325060 0.77 HSD11B1 (0.62) HSD11B1MAPTLMNATSHRHTT
SCHEMBL3321735 0.76 HSD11B1 (0.86) HSD11B1CYP3A4CYP2D6CYP2C9TSHR
SCHEMBL5789146 0.76 HSD11B1 (0.67) HSD11B1CYP3A4CYP2D6CYP2C9HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120789-A1 Compound STERIX LIMITED (GB) 2010-05-13 US disclosed
US-20100120789-A1 Compound STERIX LIMITED (GB) 2010-05-13 US disclosed
US-20100120789-A1 Compound STERIX LIMITED (GB) 2010-05-13 US disclosed
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors STERIX LIMITED (GB) 2009-02-12 US disclosed
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors STERIX LIMITED (GB) 2009-02-12 US disclosed
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors STERIX LIMITED (GB) 2009-02-12 US disclosed
EP-1861384-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS Sterix Limited (GB) 2007-12-05 EP disclosed
WO-2006100502-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS STERIX LIMITED (GB) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042929-A1 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors HSD3B1, HSD3B2, HSD11B1 HSD11B1 3/4885CYP3A4 72/4885CYP2D6 108/4885
US-20100120789-A1 Compound NR0B2, NR0B1, NR4A1 HSD11B1 73/4885CYP3A4 100/4885CYP2D6 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.